There are training implication for those healthcare professinals who will use TcB monitors. Accuracy in interpreting and acting upon findings is paramount in the prevention of hyperbilirubinaemia and subsequent morbidity. Accessibility of the recommended tools needs careful consideration within teams to ensure no delay in identifying neonatal jaundice, particularly across a wide geographical ar
ea. The guideline recommends serum bilirubin if TcB monitors are not available. Careful consideration of this invasive procedure versus the overall cost savings in using TcB monitoring needs to be undertaken by healthcare commissioners.